CAS No. 75403-51-9

1,9-dimethyloctahydro[1,3,2]diazaphosphinino[1,2-a][1,3,2]diazaphosphinine

1,9-dimethyloctahydro[1,3,2]diazaphosphinino[1,2-a][1,3,2]diazaphosphinine
CAS 75403-51-9 molecular structure
Product Code
833699
Product Name
1,9-dimethyloctahydro[1,3,2]diazaphosphinino[1,2-a][1,3,2]diazaphosphinine
CAS Number
75403-51-9
Molecular Formula
C8H18N3P

About 1,9-dimethyloctahydro[1,3,2]diazaphosphinino[1,2-a][1,3,2]diazaphosphinine

1,9-dimethyloctahydro[1,3,2]diazaphosphinino[1,2-a][1,3,2]diazaphosphinine is a chemical compound registered under CAS number 75403-51-9, with the molecular formula C8H18N3P and a molecular weight of about 187.22 g/mol. ChemicalsProvider supplies 1,9-dimethyloctahydro[1,3,2]diazaphosphinino[1,2-a][1,3,2]diazaphosphinine for laboratory research and bulk production; product code 833699. Send an inquiry for purity, packaging, price and lead time.

CAS Number
75403-51-9
Molecular Formula
C8H18N3P
Molecular Weight
187.22 g/mol
Related Keywords
diazaphosphinino
diazaphosphinine
dimethyloctahydro
  • 1-Cyclopentene-1-carboxylic acid, 2-[[(nonafluorobutyl)sulfonyl]oxy]-,methyl ester
  • 2,4(1H,3H)-Quinazolinedione,1-[2-[(1-methyl-1H-imidazol-5-yl)methyl]-3-phenylpropyl]-3-phenyl-,bis(trifluoroacetate)
  • 2,4(1H,3H)-Quinazolinedione, 3-(2-phenylpropyl)-
  • 2(1H)-Quinolinone,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-1-ethyl-4-hydroxy-
  • 2,8-Decadienedioic acid, (2E,8E)-
  • 2(1H)-Quinolinone,1-[(4-bromophenyl)methyl]-3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-
    477931-70-7
  • 2,4(1H,3H)-Quinazolinedione,1-[3-(1H-imidazol-1-yl)propyl]-3-(4-nitrophenyl)-
  • 2,4(1H,3H)-Quinazolinedione, 1-butyl-7-methyl-
  • 2,8-Dioxa-3-azaspiro[4.5]deca-6,9-diene-1,4-dione, 7,9-diphenyl-
  • 2,8-Diazaspiro[4.5]decan-1-one,8-[1-(4-chlorophenyl)cyclohexyl]-4-phenyl-
  • 2,4(1H,3H)-Quinazolinedione, 3-(2,6-diethylphenyl)-7-nitro-
  • Acetic acid, [2-(3-bromo-5-fluorobenzoyl)-4-chlorophenoxy]-
    875145-48-5
  • 2,4(1H,3H)-Quinazolinedione,1-[3-(1H-imidazol-1-yl)propyl]-3-[3-(trifluoromethyl)phenyl]-
  • [1]Benzopyrano[4,3-c]pyrazole,2-acetyl-2,3,3a,4-tetrahydro-3-(3-hydroxyphenyl)-
  • 2,8-Diazaspiro[4.5]decane,8-[[[(6-chloro-2-naphthalenyl)sulfonyl]amino]acetyl]-2-(4-pyridinyl)-
  • 2,4(1H,3H)-Quinazolinedione,3-(4-bromophenyl)-1-[3-(1H-imidazol-1-yl)propyl]-
  • 2(1H)-Quinolinone, 5-amino-8-methoxy-
  • 2,4(1H,3H)-Quinazolinedione, 3-(2-propynyl)-
    1904-36-5
  • 1-Cyclohexene-1-carboxamide,2-amino-N-(4-ethoxyphenyl)-4,4-dimethyl-
  • Butanoic acid, 3-hydroxy-4-iodo-, methyl ester, (S)-
  • [1]Benzopyrano[4,3-c]pyrazole,2-acetyl-3-[2-(1,3-dioxan-2-yl)ethyl]-8-fluoro-2,3,3a,4-tetrahydro-3-phenyl-
  • 2(1H)-Quinolinone, 6-methoxy-3,4-dipropyl-
  • 2(1H)-Quinolinone, 8-bromo-4-[(2,2-dimethylpropyl)amino]-
  • 2(1H)-Quinolinone, 8-iodo-4-(trifluoromethyl)-
    590372-06-8
  • 2(1H)-Quinolinone,4-amino-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-6-nitro-
  • 2,4(1H,3H)-Quinazolinedione, 3-[3-(trifluoromethyl)phenyl]-
  • 2(1H)-Quinolinone,4-amino-3-[5-(3,5-dimethyl-1-piperazinyl)-1H-benzimidazol-2-yl]-
  • 2,4(1H,3H)-Quinazolinedione,3-(1,3-benzodioxol-5-yl)-1-[3-(1H-imidazol-1-yl)propyl]-
  • 2,8,9-Triaza-1-phosphabicyclo[3.3.3]undecane, 2,8,9-triethyl-5-methyl-
  • 2,4(1H,3H)-Quinazolinedione, 3-bicyclo[2.2.1]hept-2-yl-
    21822-92-4
  • 2(1H)-Quinolinone,3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)-8-nitro-
  • [3-hydroxy-2,2-bis(hydroxymethyl)propyl] (1r,4ar,4bs,10ar)-1,4a-dimethyl-7-propan-2-ylidene-3,4,4b,5,6,9,10,10a-octahydro-2h-phenanthrene-1-carboxylate
  • 2-Hexen-1-one,1-[5-fluoro-2-(phenylmethoxy)phenyl]-3-phenyl-6-[(tetrahydro-2H-pyran-2-yl)oxy]-
  • 2,4(1H,3H)-Quinazolinedione, 1-[3-(1H-imidazol-1-yl)propyl]-3-phenyl-,monohydrochloride
  • 2,8-Dioxa-11-thia-3-aza-7-phosphatetradecanoic acid,3-[(1,1-dimethylethoxy)carbonyl]-7-[2-[(2,2-dimethyl-1-oxopropyl)thio]ethoxy]-13,13-dimethyl-12-oxo-, 1,1-dimethylethyl ester, 7-oxide
  • 2,8-Dibenzofurandicarboxylic acid,bis[3-[bis(3-methylbutyl)amino]propyl] ester
    30568-72-0